Of note, the combination of increased HBx–NF-κB–SHP2 pathway activity and increased STAT3 signaling in non-neoplastic background liver tissues suggests that these two signals are necessary for preventing HCC progression. The gene discussed is PTPN11; the disease is hepatocellular carcinoma.